Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin for Prevention of Severe COVID-19
NCT04886362Phase 3Unknown
- Sponsor
- Ayudas Diagnosticas Sura S.A.S.
- Start
- Jul 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ivermectin in coronavirus disease 2019 (COVID-19), sponsored by Ayudas Diagnosticas Sura S.A.S.. Status: unknown.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04886362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04886362.